Evidence map›Paper›PMID 40272931›Full record

ArticleJournal of aerosol medicine and pulmonary drug delivery2025

Preclinical Testing of a New Dry Powder Aerosol Synthetic Lung Surfactant Formulation and Device Combination for the Treatment of Neonatal Respiratory Distress Syndrome.

Worth Longest, Michael Hindle, Dale Farkas, Mohammad A M Momin, Caleb Dalton, Felicia Hall, Ghali Aladwani, Hattie KenKnight, Robert M DiBlasi

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of aerosol medicine and pulmonary drug delivery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Worth LongestDepartment of Mechanical and Nuclear Engineering, Virginia Commonwealth University, Richmond, Virginia, USA.ORCID 0000-0003-4939-5691
Michael HindleDepartment of Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia, USA.ORCID 0000-0002-1025-1183
Dale FarkasDepartment of Mechanical and Nuclear Engineering, Virginia Commonwealth University, Richmond, Virginia, USA.
Mohammad A M MominDepartment of Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia, USA.
Caleb DaltonDepartment of Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia, USA.
Felicia HallDepartment of Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia, USA.
Ghali AladwaniDepartment of Mechanical and Nuclear Engineering, Virginia Commonwealth University, Richmond, Virginia, USA.
Hattie KenKnightCenter for Respiratory Biology and Therapeutics, Seattle Children's Research Institute, Seattle, Washington, USA.
Robert M DiBlasiCenter for Respiratory Biology and Therapeutics, Seattle Children's Research Institute, Seattle, Washington, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dry Powder InhalersLungPulmonary SurfactantsRespiratory Distress Syndrome, NewbornAdministration, InhalationAerosolsAnimalsAnimals, NewbornChemistry, PharmaceuticalDisease Models, AnimalEquipment DesignExcipientsParticle SizePowdersRabbitsSpray DryingAerosolsExcipientsPowdersPulmonary Surfactantsaerosol surfactant therapyinfant aerosol therapyneonatal RDSsurfactant replacement therapysynthetic lung surfactant

Identifiers

PMID40272931
PMCPMC12433280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.